Cargando…
Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway
BACKGROUND: Erlotinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, demonstrated therapeutic efficacy against pancreatic cancer. However, acquired resistance to erlotinib in pancreatic cancer is widely observed, and the exact mechanisms have not been fully expl...
Autores principales: | Xu, Huiting, Chen, Runzhi, Shen, Qian, Yang, Dongmei, Peng, Hui, Tong, Jin, Fu, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450525/ https://www.ncbi.nlm.nih.gov/pubmed/34552882 http://dx.doi.org/10.3389/fonc.2021.754146 |
Ejemplares similares
-
Circular RNA hsa_circ_0000658 inhibits osteosarcoma cell proliferation and migration via the miR‐1227/IRF2 axis
por: Jiang, Xin, et al.
Publicado: (2020) -
circTNFRSF21, a newly identified circular RNA promotes endometrial carcinoma pathogenesis through regulating miR-1227-MAPK13/ATF2 axis
por: Liu, Yun, et al.
Publicado: (2020) -
COLLABORATION AGREEMENT No. K1227
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2006) -
COLLABORATION AGREEMENT K1227/AT
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2006) -
DNA methylation and miR‐92a‐3p‐mediated repression of HIP1R promotes pancreatic cancer progression by activating the PI3K/AKT pathway
por: Zhu, Sixian, et al.
Publicado: (2023)